Fundz

D Tx Pharma, Inc. reported raising $100 Million in an initial SEC Form D filing, from an offering of $100 Million

PRIVATEMar 10, 2021$100.2M of $100.2M raised

Amount Raised

$100 Million

$100 Million sold, per SEC Form D (first sale Mar 10, 2021)

Round Type

Venture

San DiegoBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

DTx Pharma, Inc. raised $100 Million in a funding round, dated March 10, 2021. DTx Pharma, Inc. is based in San Diego, California, United States.

How much did DTx Pharma, Inc. raise?
DTx Pharma, Inc. raised $100 Million in a funding round on March 10, 2021.
What does DTx Pharma, Inc. do?
DTx Pharma, Inc. is a privately held biotechnology company, addressing the challenges associated with delivering RNA-based therapeutics beyond the liver with the company's proprietary Fatty Acid Ligand Conjugated..
Where is DTx Pharma, Inc. based and how big is it?
DTx Pharma, Inc. is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as DTx Pharma, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $6M (Series A) on April 20, 2021.
  • Azora Therapeutics, Inc. (DE) raised $291K on March 26, 2021.
  • Century Therapeutics, Inc. raised an undisclosed amount on March 15, 2021.
  • Phio Pharmaceuticals raised $14M on February 16, 2021.
  • Design Therapeutics, Inc. raised $125M on February 12, 2021.
  • ISOThrive raised $5.2M on February 5, 2021.

Who to call at DTx Pharma, Inc., and when

A new round usually means DTx Pharma, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DTx Pharma, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DTx Pharma, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DTx Pharma, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DTx Pharma, Inc.

Location

10655 Sorrento Valley Rd #100

San Diego, California, United States

About

DTx Pharma, Inc. is a privately held biotechnology company, addressing the challenges associated with delivering RNA-based therapeutics beyond the liver with the company's proprietary Fatty Acid Ligand Conjugated OligoNucleotide (FALCONTM) technology platform. The FALCON platform leverages fatty acids for enhanced biodistribution and cellular uptake to tissues and cell types throughout the body. In preclinical studies, FALCON siRNAs have demonstrated potent and durable repression of target genes in the peripheral nervous system (PNS), skeletal muscle, heart, skin and CNS. FALCON siRNAs can be delivered by intravenous, subcutaneous and intrathecal routes of administration and can be manufactured at relatively low cost. The company has a pipeline focused on PNS, CNS and neuromuscular diseases. DTx Pharma has raised more than $115M in combined investment from several of the world's leading healthcare investors including RA Capital Management, Access Biotechnology, Surveyor Capital (a Citadel company), Eli Lilly and Company, Friedman Bioventure, Viva Biotech Holdings, as well as support from research foundations including the CMT Research Foundation (CMTRF) and the National Institutes of Health. To learn more about DTx Pharma, please visit www.dtxpharma.com and follow DTx on LinkedIn and Twitter @DTxPharma.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DTx Pharma, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for DTx Pharma, Inc.'s next move

See what Strategic adds

DTx Pharma, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.